4: General Responses of Cell-Mediated vs Humoral Activity

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

48 Terms

1
New cards

Effector CTL activation (3 signals)

  1. TCR:MHC class I (via w/ licensed APC)

  2. costimulatory signal through CD28/CD80/86 on DC

  3. high affinity IL-2R binding to IL-2


2
New cards

Signal one of CTL activation

  1. DC binds to TH1 w/ CD40 and MHC-II → DC becomes licensed by TH1

  2. DC becomes licensed, performs cross-presentation: presenting peptides on MHC-I that would normally go on MHC-II

  3. CTL differentiation/proliferation: naive CD8 T cell & DC bind via MHC-I and TCR; CD80/86 & CD 28

(steps occur simultaneously)

3
New cards

What are the two ways a CTL kills a target?

  1. Granule exocytosis (granzyme & perforin-mediated cytolysis)

  2. Fas:FasL signaling


4
New cards

Granzyme and Perforin-mediated cytolysis

intrinsic pathway of apoptosis

after CTL forms conjugate w/ target cell, releases perforce and granzymes into space between cells → pokes holes in target cell membrane and leads to cell death

5
New cards

Fas/FasL-Mediated Cytolysis

extrinsic pathway of apoptosis

FasL/Fas binding delivers death signal

6
New cards

Fas mutations result in what?

lymphoproliferation disorders; swollen lymph node tissue leading to autoimmunity

7
New cards

how are NK cells similar/different to CTLs?

similar: similar apoptotic pathways in target cells

different: NKs don’t need to be activated (activate rapidly by INF-a/b), controls pathogen within first 7 days (time it takes CTLs to develop), activity peaks after 3 days of infection

8
New cards

2 types of receptors on NK cells

  1. activating receptors (bind to cell surface ligands that indicate infection, cancer, stress)

  2. inhibitory receptors (recognize membrane proteins like MHC on normal cells and inhibit killing)


9
New cards

missing self model

if cell has no MHC-I, NK will kill it

(virally infected and tumor cells down regulate MHC-I to avoid CD8 activation)

10
New cards

balanced signals model

balance of inhibitory/activating signals from receptors recognizing ligands on target cell determines if NK will kill it

11
New cards

3 signals of T-dependent B-cell responses (how B cells get activated to protein antigens)

  1. BCR binds antigen & expresses it on MHC-II, recruiting T-cell help

  2. Activated TH cell binds to B-cell (TCR/MHCII, CD40/CD40L on TH cell)

  3. T cell releases cytokines that activate B-cell


12
New cards

What makes a B cell more effective at eliciting T-cell help?

more antigen taken in (b/c more peptide expressed on MHC-II)

BCR signaling also increases expression of costimulatory molecules (CD80/86/40)

13
New cards

What does T cell help ensure?

only B-cells taking in a high level of antigen can get T-cel help and make antibodies to that antigen

14
New cards

what do B cells differentiate into after T-dependent antigen activation?

plasma cells

memory cells

germinal center B cells

15
New cards

What are the first B-cells to produce antibodies after T-cell help?

antibody-forming cells (AFCs): plasma cells and plasmablasts

(useful b/c immediately have antibodies to target pathogen, but low affinity antibodies)

16
New cards

plasmablasts

state between naive B cell and plasma cell

express some BCRs and secrete antibodies; become fully differentiated after taking in more antigen

17
New cards

AFC foci produce what antibodies? How? Do they undergo somatic hypermutation?

initially produce only IgM, after 5-6 days, class switch recombination occurs and IgG antibodies are produced instead

(these antibodies do not under go SHM → lower affinity)

18
New cards

how are germinal centers formed?

activated B cells enter the follicle, divide rapidly and undergo further differentiation

19
New cards

How are GC B-cells so high affinity?

somatic hypermutation

better affinity cells go through more rounds of mutation/selection (no or reduced affinity → apoptosis)

20
New cards

CSR/class switch recombination

RNA splicing that changes constant region of antibody, changing antibody class

21
New cards

CSR in GC B-cells

IgM constant region becomes IgG, IgA, IgE

22
New cards

how do GC B cells proliferate?

enter follicles (secondary lymphoid structures) and colocalize with FDCs → original naive B cells pushed to periphery (mantle zone)

23
New cards

What cell provides anti-apoptotic signals to GC B cells?

T follicular helper cells (TFH), since GC B cells are highly susceptible to apoptosis

24
New cards

early memory B cells

formed before germinal center formed, mostly form IgM

low affinity for antigen

25
New cards

GC memory B cells

mutated, high-affinity receptors (SHM)

gradually sift from IgM to mostly other classes of antibodies via CSR

26
New cards

6 effector mechanisms of antibodies

  1. neutralization

  2. agglutination

  3. opsonization

  4. complement activation

  5. ADCC (antibody-dependent cell-mediated cytotoxicity)

  6. degranulation


27
New cards

neutralization by antibodies definition. when is it ineffective?

antibodies bind to cell-surface proteins, preventing virus/bacteria from binding to cell and internalizing

also neutralize toxins

ineffective in stopping pathogens that mutate rapidly

28
New cards

agglutination by antibodies

antibodies bind multiple pathogens using their multiple binding sites, allows clearance of pathogens (such as mucus or pushing out from the lungs)

29
New cards

Opsonization, antibody dependent cellular phagocytosis

antibodies bind antigen and FcRs on phagocytic cells to trigger phagocytosis

30
New cards

Complement Activation

antigen-antibody complexes (IgM, IgG) initiate complement cascade

31
New cards

ADCC (antibody-dependent cell-mediated cytotoxicity)

antibodies bind to foreign antigens on cells and recruit cytotoxic cells (NK cells have Fc receptor that triggers release of perforin, granzyme)

32
New cards

IgM

(pentameter = 10 binding sites)

natural antibodies (can be prod. w/o antigen)

effective at activating complement and pathogen lysis

good at agglutinating pathogens

33
New cards

IgG

most common antibody in serum

bind to FcR and enhance phagocytosis by macrophages

IgG1, IgG3 activate complement

IgG1 induces ADCC by NK cells

34
New cards

IgA

major antibody class found in secretions, agglutination

stimulate phagocytosis, ADCC, degranulation

forms dimers to neutralize toxins/pathogens

does NOT activate complement → won’t induce inflammation

35
New cards

IgE

major role in allergy and asthma

important in protection against parasitic worms/protozoa

(degranulation of eosionphils/basophils → histamine released in blood)

36
New cards

IgD

smallest amount of antibodies in blood

triggers secretion of antimicrobial peptides & cytokines

37
New cards

Fc receptors

exposed on immune cells, bind to antibodies (use antibodies to activate cell-mediated response); only signal if antibody is bound to pathogen

38
New cards

What classes of antibodies neutralize pathogens

all

39
New cards

What classes of antibodies agglutinate pathogens

IgA, IgM

40
New cards

what antibody class initiates the complement cascade to lyse pathogens directly?

IgM

41
New cards

What antibody activates complement, opsonizes pathogens, and enter tissues to interact with innate cells to promote inflammation

IgG

42
New cards

Ab for extracellular pathogens

IgG (fix complement, opsonize pathogen)

43
New cards

Ab for intracellular pathogens

IgG subtypes that activate cytotoxic cells (ADCC)

44
New cards

what Abs provide protection in secretions of mucosal/glandular tissues

IgA, IgM

45
New cards

What Abs promote degranulation of mast cells and basophils to release mediators?

IgE, IgD

46
New cards

Chimeric antibodies

mouse variable regions w/ human constant regions (therapeutically used)

47
New cards

humanized antibodies

replaces most of mouse variable region w/ human regions

48
New cards

Why is IgG used to treat so many diseases (cancer therapies, cytokine modulators, infectious diseases)

wide range of effector functions, long half life

used in cancer therapies to activate complement and mediate ADCC by NK cells